Form 4 for ELV Elevance Health
Accepted 2026-05-20 16:11:33 ET · period of report 2026-05-19 · accession 0001659075-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-20 16:11 | 2026-05-19 | ELV | Penczek Ronald W | CAO, Ctrl | M - OptEx | $294.30 | +1,531 | 5,640 | +37% | +$450.6K |
| D | 2026-05-20 16:11 | 2026-05-19 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale+OE | $403.13 | -1,531 | 4,109 | -27% | -$617.2K |
| DM | 2026-05-20 16:11 | 2026-05-19 | ELV | Penczek Ronald W | CAO, Ctrl | M - OptEx | $0.00 | -1,531 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | M | A | 654 | $271.27 | 4,763 | D | — | — | (F1) Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. |
| 2 | Common | Common Stock | 2026-05-19 | M | A | 877 | $311.48 | 5,640 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-19 | S | D | 1,531 | $403.13 | 4,109 | D | — | — | (F2) This transaction was executed in multiple trades, each at the same price of $403.13. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2026-05-19 | M | D | 654 | $0.00 | 0 | D | $271.27 · — to 2030-03-02 | 654 Common Stock | (F3) Fully vested. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-05-19 | M | D | 877 | $0.00 | 0 | D | $311.48 · — to 2031-03-01 | 877 Common Stock | (F3) Fully vested. |